Structure/function of the Soluble Guanylyl Cyclase Catalytic Domain
Overview
Authors
Affiliations
Soluble guanylyl cyclase (GC-1) is the primary receptor of nitric oxide (NO) in smooth muscle cells and maintains vascular function by inducing vasorelaxation in nearby blood vessels. GC-1 converts guanosine 5'-triphosphate (GTP) into cyclic guanosine 3',5'-monophosphate (cGMP), which acts as a second messenger to improve blood flow. While much work has been done to characterize this pathway, we lack a mechanistic understanding of how NO binding to the heme domain leads to a large increase in activity at the C-terminal catalytic domain. Recent structural evidence and activity measurements from multiple groups have revealed a low-activity cyclase domain that requires additional GC-1 domains to promote a catalytically-competent conformation. How the catalytic domain structurally transitions into the active conformation requires further characterization. This review focuses on structure/function studies of the GC-1 catalytic domain and recent advances various groups have made in understanding how catalytic activity is regulated including small molecules interactions, Cys-S-NO modifications and potential interactions with the NO-sensor domain and other proteins.
Rager C, Klopper T, Tasch S, Whittaker M, Exintaris B, Mietens A Cells. 2025; 14(1.
PMID: 39791752 PMC: 11720613. DOI: 10.3390/cells14010051.
Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts.
Rudman-Melnick V, Vanhoutte D, Stowers K, Sargent M, Adam M, Ma Q Sci Rep. 2024; 14(1):29307.
PMID: 39592775 PMC: 11599588. DOI: 10.1038/s41598-024-80930-0.
Use of Olives-derived Phytochemicals for Prevention and Treatment of Atherosclerosis: An Update.
Dabravolski S, Pleshko E, Sukhorukov V, Glanz V, Sobenin I, Orekhov A Curr Top Med Chem. 2024; 24(25):2173-2190.
PMID: 39162269 DOI: 10.2174/0115680266314560240806101445.
The discovery of hidden guanylate cyclases (GCs) in the proteome.
Turek I, Freihat L, Vyas J, Wheeler J, Muleya V, Manallack D Comput Struct Biotechnol J. 2023; 21:5523-5529.
PMID: 38022692 PMC: 10665587. DOI: 10.1016/j.csbj.2023.11.005.
The evolution of small molecule enzyme activators.
Dow L, Case A, Paustian M, Pinkerton B, Simeon P, Trippier P RSC Med Chem. 2023; 14(11):2206-2230.
PMID: 37974956 PMC: 10650962. DOI: 10.1039/d3md00399j.